483 Amphastar Pharmaceuticals Feb 2006

483 Amphastar Pharmaceuticals Feb 2006

Jennifer Gogley FDA, John Gonzalez FDA, Caryn Mcnab FDA$119.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observations (via FDA 483) on 23 Feb 2006.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Feb 2006
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart